252 related articles for article (PubMed ID: 18592931)
1. Editorial: Antithrombotic management early after mechanical heart valve replacement.
Hering D; Piper C; Horstkotte D
J Heart Valve Dis; 2008 May; 17(3):332-4. PubMed ID: 18592931
[No Abstract] [Full Text] [Related]
2. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
[TBL] [Abstract][Full Text] [Related]
3. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
4. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
Meurin P; Tabet JY
Heart; 2008 Feb; 94(2):131-2. PubMed ID: 18195116
[No Abstract] [Full Text] [Related]
5. [Antithrombotic therapy in patients with mechanical valve prostheses].
Roudaut R; Lorient-Roudaut MF
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1543-50. PubMed ID: 9092416
[TBL] [Abstract][Full Text] [Related]
6. Anti-Xa activity with low-molecular-weight heparin, enoxaparin, during pregnancy in women with mechanical heart valves.
Izaguirre R; De La Peña A; Ramírez A; Cortina E; Huerta M; Salazar E
Proc West Pharmacol Soc; 2002; 45():127-8. PubMed ID: 12434554
[No Abstract] [Full Text] [Related]
7. [Evidence for thrombosis prophylaxis to high-risk patients].
Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
[No Abstract] [Full Text] [Related]
8. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin.
Bauersachs R; Lindhoff-Last E
Arch Intern Med; 2003 Dec 8-22; 163(22):2788-9. PubMed ID: 14662636
[No Abstract] [Full Text] [Related]
9. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
[No Abstract] [Full Text] [Related]
10. [The current aspects of antithrombotic therapy].
Bŭcharova V
Vutr Boles; 1990; 29(3):14-20. PubMed ID: 2178290
[No Abstract] [Full Text] [Related]
11. Challenges in managing anticoagulant therapy in patients with heart valve prostheses.
Vink R; Kamphuisen PW; van den Brink RB; Levi M
Expert Rev Cardiovasc Ther; 2007 May; 5(3):563-70. PubMed ID: 17489678
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
Descarries LM; Leduc L; Khairy P; Mercier LA
J Heart Valve Dis; 2006 Sep; 15(5):679-85. PubMed ID: 17044374
[TBL] [Abstract][Full Text] [Related]
13. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
[TBL] [Abstract][Full Text] [Related]
14. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
Pelosio L; Marasco A; Puopolo G
Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
[No Abstract] [Full Text] [Related]
15. Antithrombotic therapy: the expanding role of low molecular weight heparin.
Turpie AG
Indian Heart J; 1997; 49(5):489-92. PubMed ID: 9505014
[No Abstract] [Full Text] [Related]
16. [Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics].
Nikolov A; Kovachev I; Petkov Iu; Dimitrov A
Akush Ginekol (Sofiia); 2000; 39(3):35-40. PubMed ID: 11187995
[No Abstract] [Full Text] [Related]
17. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
18. Quick, easy, and safe? On the use of low-molecular-weight heparins in cardioversion of atrial fibrillation.
Stellbrink C
Eur Heart J; 2006 Dec; 27(23):2742-3. PubMed ID: 17098755
[No Abstract] [Full Text] [Related]
19. [Low-molecular heparin in doses adapted to body weight. Management of thromboembolic diseases].
Internist (Berl); 1999 May; 40(5 Suppl Management):1-16. PubMed ID: 10367262
[No Abstract] [Full Text] [Related]
20. [Anticoagulants and platelet antiaggregants: lessons of the last 20 years].
De Moerloose P; Boehlen F
Rev Med Suisse Romande; 1998 Jul; 118(7):641-4. PubMed ID: 9708021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
